Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00597870 · ClinicalTrials.gov registry record · NA

Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions

A NA study of Thoracic Aortic Dissection and Intramural Hematoma, sponsored by Rodney A. White, M.D..

Completed
Registry status
NA
Development phase
304
Enrollment target
1
Study location

NCT00597870: Completed NA study of Thoracic Aortic Dissection and Intramural Hematoma, sponsored by Rodney A. White, M.D..

NCT00597870 is a NA study of Thoracic Aortic Dissection and Intramural Hematoma that has completed, run by Rodney A. White, M.D.. The registered enrollment target is 304 participants, below the 720-participant average among 5 other Thoracic Aortic Dissection trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00597870, a NA study of Thoracic Aortic Dissection and Intramural Hematoma, has completed, sponsored by Rodney A. White, M.D..

COMPLETED
Registry status
NA
Development phase
304 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this trial is to determine whether the Talent Thoracic Stent Graft, an investigational device, is a safe and effective method of treating thoracic aortic aneurysms (abnormal ballooning of the vessel wall) and other thoracic lesions (dissections, transections, pseudoaneurysms, penetrating ulcers, etc.). The endovascular method is a substitute for the major operation that is performed to treat the lesions.

Primary Outcome

Evaluate the number of patients who had successful treatment of their thoracic lesion using the Medtronic Talent Endoluminal Stent Graft..

Interventions

  • DEVICE Endoluminal treament of thoracic lesions

Study Locations (1)

California

  • LAC Harbor-UCLA Medical Center - Torrance

Trial Details

FieldValue
Enrollment Target 304 participants
Start Date 2002-05
Est. Completion 2021-01
Phase NA
Rodney A. White, M.D.

2 total trials

What the finished NCT00597870 record still lists

NCT00597870 is an interventional study that assigns participants to a tested intervention. The registered 304 participants enrollment target is mid-sized for trials with a published cap, below the 720-participant average among 5 other Thoracic Aortic Dissection trials with a reported enrollment target (58% lower).

The record links to 5 conditions, with Thoracic Aortic Dissection appearing as the primary indexed condition, and to 1 intervention - of which Endoluminal treament of thoracic lesions is the first listed.

NCT00597870 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00597870 about?

NCT00597870 is a clinical study titled "Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions". The primary objective of this trial is to determine whether the Talent Thoracic Stent Graft, an investigational device, is a safe and effective method of treating thoracic aortic aneurysms (abnormal ballooning of the vessel wall) and other thoracic lesions (dissections, transections, pseudoaneurysms...

What is the current status of trial NCT00597870?

This trial is currently completed. It is a NA study. The enrollment target is 304 participants. The study started on 2002-05. Estimated completion is 2021-01.

What conditions does trial NCT00597870 study?

This clinical trial studies the following conditions: Thoracic Aortic Dissection, Intramural Hematoma, Pseudoaneurysm, Thoracic Aortic Aneurysms, Thoracic Transections.

What interventions are being tested in trial NCT00597870?

The interventions under investigation include: Endoluminal treament of thoracic lesions (DEVICE).

Who is sponsoring clinical trial NCT00597870?

This trial is sponsored by Rodney A. White, M.D., which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00597870 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thoracic Aortic Dissection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04750616 · 304 participants · Phase 2

    NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

  • NCT04994717 · 304 participants · Phase 3

    Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia

  • NCT06036147 · 304 participants · NA

    Concussion Health Improvement Program

  • NCT06096844 · 304 participants · Phase 3

    Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00597870, the US trial registry maintained by the National Library of Medicine. NCT00597870 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.